Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for painful knee osteoarthrosis: open-label safety and efficacy study
2005-004301-28Phase 2Completed
- Sponsor
- Københavns Amts Sygehus i Glostrup
- Start
- Oct 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adalimumab in knee osteoarthritis (OA), sponsored by Københavns Amts Sygehus i Glostrup. Primary endpoint: WOMAC pain score change from baseline at week 12. Started Oct 2005; status: completed.
02
Drugs
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-004301-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004301-28.